Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.

Faye A SharpleyDunnya De-SilvaShameem MahmoodSajitha SachchithananthamIsobel RamsayAna Garcia MingoSarah WorthingtonDerralynn HughesAtul MehtaCharalampian KyriakouPaul D GriffithsAshutosh D Wechalekar

Published in: European journal of haematology (2020)

This study suggests that there is a substantial risk of CMV reactivation in CMV-seropositive plasma cell dyscrasia patients treated with bortezomib.

Keyphrases

multiple myeloma
single cell
cell therapy
epstein barr virus
bone marrow